Tag: SARS-CoV-2

AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs

- May 18, 2022

AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

- March 18, 2022

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More

Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment

- March 18, 2022

Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More

Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

businessnewstoday- February 20, 2022

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More

Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

- February 12, 2022

Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More

Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India

- February 9, 2022

Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter's Nitric Oxide Nasal Spray under the brand name FabiSpray in ... Read More

Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy

- February 7, 2022

Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More

Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients

- January 22, 2022

Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog Veklury (remdesivir) for the treatment of non-hospitalized ... Read More

Biocon gets license for Adagio Therapeutics’ ADG20 for Covid-19 treatment

- July 26, 2021

Biocon Limited said that its subsidiary Biocon Biologics has been given an exclusive license from Adagio Therapeutics, a US-based biotech company, for manufacturing and commercializing ... Read More

Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy

- July 4, 2021

Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of ... Read More